Liver transplantation for massive hepatic lymphangiomatosis in a child

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 3, 2011, Pages 366-369

  Ooi, Chee Y ^a   Brody, Daniel ^a   Wong, Ralph ^b   Moroz, Stan ^b   Ngan, Bo Y ^a   Navarro, Oscar M ^a   Fecteau, Annie ^a   Grant, David ^a   Ng, Vicky L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; RAPAMYCIN; SUNITINIB; TACROLIMUS;

ABDOMINAL PAIN; ARTICLE; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT VERSUS HOST REACTION; HEPATOMEGALY; HUMAN; LABORATORY TEST; LIVER TRANSPLANTATION; LYMPHANGIOMATOSIS; MALE; MASSIVE HEPATIC LYMPHANGIOMATOSIS; PERITONEAL CAVITY; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESUSCITATION; SCHOOL CHILD; SPLENOMEGALY; VOMITING;

CHILD; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHANGIOMA;

EID: 79952315597     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181ec1cfb     Document Type: Article

References (10)

1. Miller C, Mazzaferro V, Mokowka L, et al. Orthotopic LT for massive hepatic lymphangiomaotsis. Surgery 1988;103:490-5.
2. Tepetes K, Selby R, Webb M, et al. Orthotopic LT for benign hepatic neoplasms. Arch Surg 1995;130:153-6.
3. Datz C, Graziadei IW, Dietze O, et al. Massive progression of diffuse hepatic lymphangiomatosis after liver resection and rapid deterioration after LT. Am J Gastroenterol 2001;96:1278-81. (Pubitemid 32319174)
4. Ra SH, Bradley RF, Fishbein MC, et al. Recurrent hepatic lymphangiomatosis after orthotopic LT. Liver Transpl 2007;13:1593-7.
5. Busuttil RW, Klintmalm GB. LT of the Liver. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005.
6. Laverdière C, David M, Dubois J, et al. Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol 2000;29:321-4. (Pubitemid 30176646)
7. Ozeki M, Funato M, Kanda K, et al. Clinical improvement of diffuse lymphangiomatosis with pegylated interferon alfa-2b therapy: case report and review of the literature. Pediatr Hematol Oncol 2007;24:513-24. (Pubitemid 47360010)
8. Jimenez-Rivera C, Avitzur Y, Fecteau A, et al. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant 2004;8:243-8. (Pubitemid 38788551)
9. Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002;62:625-31. (Pubitemid 34126930)
10. Rini BI. Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma. Cancer 2009;115(10 Suppl):2306-12.